Ventilator associated pneumonia: mechanisms, an appraisal of current therapies and the role for inhaled antibiotics in prevention and treatment ScienceDirect ()? is a lung infection that can cause serious health complications, especially in patients with weakened immune systems. When a patient is Preventing Ventilator Associated Pneumonia (VAP) in ICU Smitha Sasidharan posted on the topic LinkedIn VENTILATOR = LIFE SUPPORT but also VAP RISK. Up to 20% of ventilated patients >48 hrs develop VAP. Mortality? Can reach 50%. Here's what actually matters in ICU rounds Pharma's New Frontier How the VAP Market is Shaping the Future of Critical Care Table 4 from Comparison of CPIS ( clinical pulmonary infection score ) and Clinical Criteria in the Diagnosis of Ventilator associated Pneumonia in ICU Complex Patients Semantic Scholar